Human DNA polymerase β polymorphism, Arg137Gln, impairs its polymerase activity and interaction with PCNA and the cellular base excision repair capacity by Guo, Zhigang et al.
Published online 31 March 2009 Nucleic Acids Research, 2009, Vol. 37, No. 10 3431–3441
doi:10.1093/nar/gkp201
Human DNA polymerase b polymorphism,
Arg137Gln, impairs its polymerase activity and
interaction with PCNA and the cellular base
excision repair capacity
Zhigang Guo, Li Zheng, Huifang Dai, Mian Zhou, Hong Xu and Binghui Shen*
Department of Radiation Biology, City of Hope National Medical Center and Beckman Research Institute,
Duarte, CA 91010, USA
Received December 28, 2008; Revised March 9, 2009; Accepted March 10, 2009
ABSTRACT
DNA polymerase b (Pol b) is a key enzyme in DNA
base excision repair, and an important factor for
maintaining genome integrity and stability. More
than 30% of human tumors characterized to date
express DNA Pol b variants, many of which result
from a single nucleotide residue substitution.
However, in most cases, their precise functional
deficiency and relationship to cancer susceptibility
are still unknown. In the current work, we show
that a polymorphism encoding an arginine to gluta-
mine substitution, R137Q, has lower polymerase
activity. The substitution also affects the interaction
between Pol b and proliferating cell nuclear antigen
(PCNA). These defects impair the DNA repair capac-
ity of Pol b in reconstitution assays, as well as in
cellular extracts. Expression of wild-type Pol b in
pol b
 /  mouse embryonic fibroblast (MEF) cells
restored cellular resistance to DNA damaging
reagents such as methyl methanesulfonate (MMS)
and N-methyl-N-nitrosourea (MNU), while expres-
sion of R137Q in pol b
 /  MEF cells failed to do so.
These data indicate that polymorphisms in base
excision repair genes may contribute to the onset
and development of cancers.
INTRODUCTION
Genomic DNA is constantly exposed to endogenous and
exogenous insults, which react with base and sugar groups
causing DNA damage which, if not repaired, may result in
genetic mutations, and subsequently contribute to genome
instabilities and cancer initiation (1,2). Removal of DNA
damage and maintenance of genomic integrity depend on
robust cellular DNA repair systems (2). Base excision
repair (BER) is one of the major repair pathways in
eukaryotic cells, processing DNA base damage caused
by endogenous and exogenous agents (3,4). It is estimated
that BER is responsible for repairing about 10
4 damaged/
modiﬁed bases per cell per day (5–7). BER is initiated with
the excision of the damaged base by a speciﬁc DNA gly-
cosylase, followed by incision of the DNA backbone by
AP endonuclease 1 (APE1) to produce a nicked abasic
intermediate (8). This intermediate structure can be pro-
cessed through either the short-patch BER (SP-BER) or
the long-patch BER (LP-BER) pathway (9,10). In the
former, DNA polymerase b (Pol b) adds only one nucleo-
tide to the 30-end of the nicked AP site, and then the dRP
lyase activity of Pol b catalyzes b-elimination of the
50-sugar phosphate residue, resulting in a ligatable nick
that can then be sealed by XRCC1/Ligase IIIa (11,12).
In the latter, Pol b or the alternative Pol d performs
strand displacement synthesis, generating a short DNA
ﬂap of 2–10nt, which is removed by ﬂap endonuclease 1
(FEN1) (13–17). DNA ligase I then seals the nick (9).
Of the tens of BER proteins identiﬁed, Pol b has been
demonstrated to be a key player in both SP- and LP-BER
(18,19). Pol b, a 39kDa protein, contains two domains; a
dRP lyase domain (8kDa) and a polymerase domain
(31kDa). These two domains correspond to the dRP
lyase and polymerase activities, which are responsible for
the removal of the sugar phosphate group and the incor-
poration of new deoxyribonucleotides, respectively (20).
In addition, Pol b also interacts with many other proteins
including XRCC1 (21–25), proliferating cell nuclear anti-
gen (PCNA) (26), and FEN1 (27,28). These interactions
likely play important roles in recruiting downstream fac-
tors to the DNA repair site, reciprocally stimulating
enzyme activities and coordinating the highly ordered
chemical reactions of BER. Pol b deﬁciency has been
demonstrated to impair BER eﬃciency and to cause
cells to be hypersensitive to alkylating or oxidative
agents (15,29). Knockout of Pol b in mice abolishes
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to DNA damaging reagents, including methyl methanesul-
fonate (MMS) and N-methyl-N-nitrosourea (MNU), lead-
ing to early embryonic lethality. Pol b mutations that
aﬀect its dRP lyase, polymerase activity or its interaction
with other proteins, have been shown to result in defective
BER in vitro (30–33).
Single nucleotide polymorphisms occur widely in DNA
repair genes (34). While previous research suggests poly-
morphisms may result in biochemical alternations, BER
deﬁciency and predisposition to cancers (31,34–37), it is
still of signiﬁcant interest to determine whether and how a
polymorphism increases the susceptibility to development
of cancers. For DNA Pol b, three non-synonymous single
nucleotide substitutions were identiﬁed as polymorphisms
in humans. These are Q8R, R137Q and P242R. However,
it is unknown whether the polymorphism aﬀects Pol
b’s function and contributes to cancer initiation and
development. Among the three DNA Pol b polymorph-
isms, R137Q is particularly interesting because the residue
at position 137 locates in the helix 7 of Pol b protein (38)
and forms salt bridges with other adjacent amino acid
residues. The amino acid substitution of Arg by Gln
results in a net positive charge loss and might lead to sig-
niﬁcant alterations in biochemical and physiological prop-
erties of the enzyme. Moreover, a recent report showed
that R137 is also a methylation site of Pol b (39). In the
current study, we expressed and puriﬁed the R137Q Pol b
variant and found that R137Q signiﬁcantly reduced poly-
merase activity. It also showed impaired interaction with
PCNA. As a result, the R137Q substitution reduced BER
eﬃciency when assayed in a reconstitution assay or with
cellular extracts. Furthermore, mouse cells expressing the
R137Q variant accumulated DNA damage lesions in the
genome and were sensitive to DNA damaging agents.
These results suggest that the R137Q polymorphism
aﬀected Pol b biochemical activity resulting in defective
BER, which might subsequently contribute to genome
instability and cancer development.
EXPERIMENTAL PROCEDURES
Preparation of recombinant wild-type and variant Pol b
The wild-type (WT) human pol   cDNA was cloned from
a human cDNA library. R137Q substitution was obtained
by site-directed mutagenesis using the primers shown in
Table 1. WT and R137Q genes were inserted into the
pET28b vector and expressed in Escherichia coli strain
BL21. Expressed proteins were puriﬁed as previously
described (40).
In vitro polymerase activity assay
The polymerase activity assay utilized 50mM Tris–HCl
(pH 8.0), 10mM MgCl2, 2mM DTT, 20mM NaCl,
10% glycerol, 0.1mM biotin-labeled DNA substrate Pol-
GAP (see Table 1 and Figure 1A for detail), 50mM each
dATP, dGTP and dTTP (Sigma), 8mM2 mCi [a-
32P]-
dCTP and 0–10ng WT or R137Q Pol b. Reactions were
carried out at 378C for 30min. A portion of reaction prod-
uct was taken out and incubated with avidin–Sepharose
4B beads, washed and quantiﬁed on liquid scintillation
analyzer. The left portion of reaction product was then
stopped by addition of equal volumes of gel loading
buﬀer (90% formamide dye, 3M EDTA, 0.02% bromo-
phenol blue and 0.02% xylene cyanol), heated (5min,
958C), separated by 15% Polyacrylamide gel electro-
phoresis (PAGE) containing 8M urea and visualized by
autoradiography.
DNA-binding assay
Gel shift and ELISA-based isothermal absorption assays
were used to compare the DNA-binding aﬃnity between
WT and R137Q Pol b. For gel shift assays, various con-
centrations of Pol b protein (0.1–1000nM) were incubated
(15min, room temperature) with 0.1nM radio-labeled
Pol-GAP substrate in a buﬀer containing 50mM Tris–
HCl (pH 8.0), 100mM NaCl, 10mM MgCl2, 10% glycerol
and 0.1% NP-40. Samples were run on a 5% native poly-
acrylamide gel and visualized by autoradiography. For
ELISA-based aﬃnity assays, biotin-labeled Pol-GAP
DNA substrate (1 pmol) was immobilized on a streptavi-
din-coated 96-well Enzyme-Linked ImmunoSorbent
Assay (ELISA) plate and washed three times with binding
buﬀer, followed by the addition of 0–1mg WT or R137Q
Pol b and incubated (overnight, 48C). Bound Pol b was
detected by mouse anti-Pol b antibody (Genetex,
GTX23181) and goat anti-mouse IgG/HRP (Genetex,
GTX85313). Color was developed by adding tetramethyl
benzidine (TMB) and stopped by addition of 1N HCl.
The OD450 was read on a microplate reader.
dRP lyase assay
The dRP lyase assay using puriﬁed Pol b protein was
performed as described previously (41). To prepare the
dRP lyase substrate, the DNA substrate Pol b-U was
labeled with (g-
32P)-ATP at the 50-end on the U-contain-
ing oligonucleotide, followed by treatment with uracil-
DNA glycosylase (UDG) and APE1. The incised AP-
site-containing DNA was then incubated (20min, 378C)
with Pol b (0–10ng) in a buﬀer containing 50mM HEPES
(pH 7.5), 10mM MgCl2, 20mM KCl and 2mM DTT,
stabilized by addition of 2M sodium borohydride to
a ﬁnal concentration of 340mM, followed by incubation
on ice (30min). Formamide-containing gel loading buﬀer
was then added and reaction products were resolved on
15% polyacrylamide gels containing 8M urea and visua-
lized by autoradiography.
Reconstituted base excision repair assay
The BER assay was performed as described previously
(22,42,43). Complete repair reactions were carried out in
20ml of reaction buﬀer [40mM HEPES–KOH (pH 7.8),
70mM KCI, 7mM MgCl2, 1mM dithiothreitol, 0.5mM
EDTA, 2mM ATP, 50mM each of dATP, dTTP and
dGTP, and 8mM2 mCi (a-
32P)-dCTP]. For short-patch
reconstitution with puriﬁed proteins, UDG (8ng), APE1
(2ng), Ligase IIIa (20ng) and various amounts of Pol b
(0–5ng), were mixed and incubated with the SP-BER
substrate Pol b-U (Table 1). For LP BER, Pol b-F sub-
strate (Table 1) was incubated with the mixture of APE1
3432 Nucleic Acids Research, 2009, Vol. 37,No. 10(2ng), Pol b (0–5ng), FEN1 (2ng), and Ligase I (20ng).
Note that in the LP-BER substrate, radio-labeled dCTP
can only be incorporated in the second position next to
the damaged base. For cell extract reconstitution, SP- or
LP-BER DNA substrate was incubated with the total
cell extracts (0–5mg). Reactions (30min, 378C) were then
stopped by adding an equal volume of the gel loading
buﬀer and visualized by autoradiography.
Cell lines and culture
WT and pol   null (pol  
 / ) mouse embryonic ﬁbroblast
(MEF) cells were described previously (15). Cells were
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Figure 1. The Pol b polymorphism R137Q is defective in polymerase activity. (A) Top panel, schematic of the biotin-labeled 1-nt gapped DNA substrate
(Pol-GAP); bottom panel, polymerase activity assay in which Pol-GAP was incubated with 50 mM each of dATP, dGTP, dTTP and 8 mM dCTP-
32P and
varying amounts of puriﬁed Pol b protein (WT and R137Q). WT and R137Q DNA polymerization products were separated by denaturing gel
electrophoresis and visualized with a phosphorimager. (B) DNA polymerization products were pulled down by Sepharose–avidin beads. After washing,
the amount of radio-nucleotide incorporated into the products was determined by liquid scintillation counting. (C) Gel shift assay of DNA-binding
aﬃnity of R137Q and WT Pol b. In this assay, Pol-GAP was labeled by
32P as shown in ﬁgure. (D) ELISA-based isotherm adsorption assay of
DNA-binding aﬃnity of R137Q and WT Pol b. The DNA substrate was the same as that used in (A). WT, ﬁlled squares; R137, ﬁlled circles.
Table 1. Oligonuleotide sequences and their applications in this study
Name Oligonuleotide sequence Application
Pol b R137Q F 50-gat aaat t gaaccat cagcaaat t gggct gaaat t t t ggg-30 Mutagenesis
Pol b R137Q R 50-cccaaaat at t t cagcccaat t t gct gat gat ggt t caa t t ta tc-30
Pol-GAP 50-ct t acacgt t gact accgt t t t gaggcaagagt ggat cc-30a Polymerase activity and DNA binding assay
30-gaat gt gcaact gat ggcagaaac t ccgt t c t cacc t agg-50
Pol b-U 50-c t tacacg t tgac tacc t tUt t tgaggcaagag t gga t cc-30b SP-BER and dRp lyase assay
30-gaat gt gcaact gat ggcagaaac t ccgt t c t cacc t agg-50
Pol b-F 50-c t tacacg t tgac tacc t t Ft t tgaggcaagag t gga t cc-30c LP-BER assay
30-gaat gt gcaact gat ggcagaaac t ccgt t c t cacc t agg-50
aP: phosphate group.
bU: uracil.
cF: Tetrahydrofuran (THF).
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medium supplemented with 10% FBS and 100 units each
of penicillin, streptomycin and hygromycin. The pol  
 / /
WT and pol  
 / /R137Q stable cell lines were generated
by using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. Selection was carried out
using 100mg/ml of G418.
Preparation of cell extracts
Cell extracts were made according to Biade et al. (43).
Brieﬂy, cells were cultured in 10cm
2 dishes, incubated
overnight to reach a mid-exponential growth phase,
washed three times with ice-cold PBS and resuspended
at 10
6cells/20ml in buﬀer I [10mM Tris–HCl (pH 7.8)
and 200mM KCl]. After the addition of an equal
volume of Buﬀer II [10mM Tris–HCl (pH 7.8), 200mM
KCl, 2mM EDTA, 40% glycerol, 0.2% NP-40, 2mM
dithiothreitol, 0.5mM PMSF and protease inhibitor cock-
tail (Roche)], the cell suspension was rocked (1h, 48C),
centrifuged (10min, 16000g) and the supernatant
recovered and stored ( 808C). Protein concentrations
were determined by Bradford protein assay.
Pull-down assay
To determine the interaction between R137Q and proteins
in the BER complex, His-tagged Pol b protein (20mg) was
mixed with cell extract prepared from the pol  
 /  MEF
cell line (50mg) in 150ml binding buﬀer [50mM Tris–HCl
(pH 7.6), 75mM KCl, 1mM DTT, 10mM imidazole],
incubated (60min, on ice) and 15ml of pre-equilibrated
nickel beads were added to the mixture which was
once again incubated (1h, on ice, with constant shaking).
Beads were then washed ﬁve times with the binding buﬀer,
suspended in SDS–PAGE sample buﬀer (50ml) (31),
boiled (5min, 958C) and the supernatant subjected to
SDS–PAGE followed by western blotting with antibodies
against APE1 (Genetex, GTX70132), FEN1 (Genetex,
GTX70186), PCNA (Genetex, GTX70286), Ligase IIIa
(Genetex, GTX70144), Ligase I (Genetex, GTX70142)
and XRCC1 (Genetex, GTX70262). To conﬁrm the inter-
action between Pol b and PCNA, puriﬁed PCNA was
immobilized on Sepharose 4B, as previously described
(40); PCNA coated beads were then mixed with puriﬁed
WT or R137Q Pol b. After incubation (60min, on ice) and
washing with binding buﬀer, Sepharose 4B beads were
boiled in SDS–PAGE sample buﬀer and the supernatant
analyzed by western blotting with anti-Pol b and PCNA
antibodies.
DNA damage assay
DNA damage assay was carried out as described (44).
Brieﬂy, monolayer cells were treated (1h) with MMS
at diﬀerent concentrations, collected and genomic DNA
was extracted by using DNAzol reagent (Invitrogen).
Extracted DNA was then coated onto ELISA plates and
detected by AP-site speciﬁc reagent, Aldehyde-Reactive
Probe (ARP) (Invitrogen), followed by detection with
HRP-conjugated streptavidin and TMB. After stopping
by 1N HCl, OD450 was measured on a microplate reader.
MMS and MNU sensitivity assay
Sensitivity to MMS and MNU was determined by HeLa
cell growth inhibition assay. HeLa cells were seeded
(1500/well), incubated (overnight, 378C). Treated (1h,
378C) with multiple dilutions of MMS, washed in a
fresh medium (DMEM containing 10% fetal bovine
serum) and incubated (72h) under normal growth condi-
tions (378C, 5% CO2). The number of viable cells was
determined by the CellTiter 96 AQueous one-solution
cell proliferation assay (Promega). At least four replicas
for each clone were averaged. Data are expressed as the
percentage of growth relative to untreated controls.
Cell apoptosis analysis
The cell cycle distribution and apoptosis of stably com-
plemented cell lines were analyzed by Fluorescence
Activated Cell Sorting (FACS) analysis, as previously
described (45). Harvested cells (10cm
2 dish) were ﬁxed
with pre-chilled 70% ethanol, stained with propidium
iodide (PI; Sigma) and analyzed by ﬂow cytometry at
the City of Hope Flow Cytometry Core Facility.
RESULTS
The R137Q variant is defective in polymerase activity
The Pol b polymorphism (rs12678588) encoding an
Arg137 to Gln substitution was initially identiﬁed by
the Human Genome Project and was conﬁrmed by
Mohrenweiser et al. (46). This polymorphism has been
identiﬁed in Caucasians, Africans and Asians with rare
occurrence frequency (National Center for Biotechnology
Information database and reference 38). However, the
extent of the impact of this polymorphism on disease
development, especially carcinogenesis, has not been
fully elucidated. To determine the eﬀects of the R137Q
Pol b variant on biochemical activities and/or biological
functions, we ﬁrst expressed and puriﬁed WT and R137Q
human Pol b proteins, and then assayed the primer exten-
sion, dRP lyase and substrate-binding activity in vitro,
using synthetic DNA substrates (Table 1). We found
that the R137Q variant had  30% primer extension activ-
ity compared to the WT enzyme (Figure 1A and B). How-
ever, no diﬀerences were observed in the R137Q variant
for the DNA-binding activity or dRP lyase activity
(Figures 1C, D and 2). These results were consistent
with the fact that R137Q occurred at the 31-kDa
domain, the polymerase catalytic domain, while the
8-kDa domain was responsible for dRP lyase and DNA-
binding activity.
The R137Q variant has an impaired interaction with PCNA
We then investigated the eﬀects of R137Q substitution on
protein–protein interactions. Extracts of pol  
 /  MEF
were incubated with puriﬁed WT or R137Q proteins
(His-tagged) prior to immunoprecipitation of proteins
involved in the BER pathway and detection by corre-
sponding antibodies (Figure 3). Six proteins (APE1,
FEN1, PCNA, XRCC1, Ligase I and Ligase IIIa)
that interact with Pol b and are involved in either the
3434 Nucleic Acids Research, 2009, Vol. 37,No. 10SP- or LP-BER pathways were investigated. The amount
of APE1, FEN1, XRCC1, Ligase 1 or Ligase IIIa that co-
pulled down with R137Q was similar to that with the WT
enzyme. However, there was a dramatic decrease in levels
of R137Q-bound PCNA compared with WT Pol b-bound
PCNA (Figure 3A, panel 2). To rule out the possibility
that the His tag itself is responsible for the observed bind-
ing, we included His-tagged glutathione S-transferase
(GST) as a control. In this case, none of the tested proteins
binds to His-tag or GST. To further conﬁrm this observa-
tion, we immobilized puriﬁed PCNA on Sepharose 4B
beads and incubated them with puriﬁed WT or R137Q
Pol b. Western blot of Sepharose bead-bound proteins
showed that WT Pol b but not R137Q was eﬃciently
pulled down by PCNA (Figure 3B), suggesting that the
Arg137 to Gln substitution impaired the interaction
between Pol b and PCNA. To quantitatively evaluate
the impact of the R137Q substitution on the Pol b/
PCNA interaction, we determined the relative amount of
WT Pol b or R137Q-bound PCNA by ELISA. Our data
suggested that levels of WT Pol b-bound PCNA were 1.5-
to 4-fold higher than those of R137Q-bound PCNA
(Figure 3C).
The R137Q variant has lower BER efficiency
The impaired biochemical functions of the R137Q variant
suggested that R137Q likely aﬀected BER function.
To test this hypothesis, SP- and LP-BER were assayed
using puriﬁed proteins. Uracil-containing substrate (Pol
b-U) and tetrahydrofuran-containing substrate (Pol b-F)
were used for SP- and LP-BER substrates, respectively
(Table 1). Cleavage of the uracil or Tetrahydrofuran
(THF) lesion by the concerted action of UDG and
APE1 resulted in a nicked DNA duplex, and incorpora-
tion of
32P-dCTP and other deoxynucleotides produced
20–30nt non-ligated intermediates visible to the phos-
phorimager (Figure 4A and B). Further processing of
this intermediate structure generated a fully repaired prod-
uct of 40nt. We observed that the uracil or THF lesions
were eﬃciently repaired in the presence of WT Pol b but
not the R137Q variant (Figure 4A and B). The reduced
repair eﬃciency by R137Q was likely due to its low-poly-
merase activity. Consistent with the polymerase activity
assays (Figure 1A), only a small amount of
32P-dCTP
was incorporated into the DNA substrate by R137Q in
reconstituted SP- and LP-BER reactions (Figure 4A and
B). To validate that the R137Q variant lead to low-BER
eﬃciency, we expressed human WT and R137Q Pol b in
mouse MEF of pol   knockout genetic background. Cells
expressing similar level of Pol b were selected (Figure 5A).
Nuclear extracts (NEs) from these cell lines were prepared
and their BER eﬃciency assayed. We found that WT NE
eﬃciently repaired the uracil or THF lesion, resulting in a
40nt band, whereas the repair eﬃciency by R137Q NE
was only  10 and 20% for SP- and LP-BER, respectively
(Figure 5B and C).
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failed to restore DNA damage resistance capacity
Our observation that R137Q Pol b caused defective
BER led us to propose that cells expressing the R137Q
variant would be sensitive to DNA base damaging
agents. To test this hypothesis, MEF cells of WT, pol  
knockout (pol  
 / ) and pol  
 /  expressing human WT
or R137Q Pol b (designated as pol  
 / /WT or pol
 / /
R137Q) were treated with MMS. Consistent with a previ-
ous report (15), we found that deletion of pol   caused
cells to accumulate MMS-induced DNA damage at MMS
concentrations  1mM (Figure 6A) and to become sensi-
tive to the MMS and MNU (Figure 6B–D). While human
WT Pol b fully complemented the function of its mouse
homolog, R137Q only partially complemented it. FACS
data showed that apoptotic cells of pol   knock out or
R137Q genetic background were considerably higher
than the WT background. Additionally, there was a
5-fold increase in MMS-induced apoptotic R137Q cells
compared with WT (3.1% versus 0.6%) (Figure 6B).
MMS consistently had a stronger inhibitory eﬀect on pol
 
 / -R137Q cell growth relative to WT or pol  
 / /WT
cells. Following MMS or MNU treatment, the ratio of
MMS or MNU treated/untreated pol  
 / -R137Q cells
was <10%, whereas that for WT or pol  
 / -WT cells
was >90% (Figure 6C and D).
DISCUSSION
Pol b plays a key role in the DNA BER pathway and
is critical for normal cell function. Approximately 30%
of human cancers contain abnormal Pol b (47). Cancer-
associated somatic mutations of pol   usually induce
genomic instability and lead to cellular transformation
when expressed in mouse ﬁbroblasts (31,48,49). Unlike
somatic mutations found in cancer patients, polymorph-
isms exist in normal populations and are hypothesized
to be liable for the onset of cancer. Given the importance
of Pol b in maintaining DNA integrity, we were
interested in providing mechanistic insights associated
with cancer development of a newly identiﬁed polymorph-
ism of Pol b, R137Q. Here, we show that the R137Q vari-
ant decreases Pol b polymerase activity and impairs its
interaction with PCNA and the overall capacity to
repair DNA base damage in vitro and in vivo. Our study
suggests that an individual with R137Q polymorphism
may be sensitive to endogenous and exogenous DNA
damaging agents, and consequently be susceptible to
cancer development.
B
WT   R137Q
anti-Pol β
anti-PCNA
C
O
D
4
5
0
 
n
m
20
10
5
25
15
Pol β input 125 500 1000 (ng/µl)
WT
R137Q
anti-FEN1
anti-PCNA
anti-Ligase 1
anti-Ligase 3a
anti-XRCC1
anti-His tag
pol b–/– cell extract
His-Pol β wt
+++
+ ––
His-Pol β R137Q – + –
Ni-NTA beads +++
A
anti-APE1
His-GST ––– +
+
–
–
+
anti-Pol β
Figure 3. The R137Q Pol b variant has an impaired interaction with PCNA. (A) Ni-NTA pull-down was performed with the cell extracts from pol  
null MEFs and puriﬁed Pol b or R137Q variant proteins (His-tagged). The interaction was detected by western blotting using antibodies against
FEN1, APE1, PCNA, Ligase 1, Ligase IIIa and XRCC1. A negative control with His-tagged GST was added to rule out the possibility that desirable
proteins interact with His tag directly. (B) Pull-down assay using puriﬁed proteins. Puriﬁed PCNA was immobilized on Sepharose 4B beads,
incubated with puriﬁed Pol b (WT or R137Q), washed and beads were then boiled in SDS–PAGE sample buﬀer. Proteins were separated by
SDS–PAGE and transferred onto PVDF ﬁlm, followed by detection with anti-Pol b and anti-PCNA antibodies. (C) Aﬃnity comparison of PCNA
with WT and R137Q Pol b by ELISA. PCNA was coated onto ELISA plates, incubated with diﬀerent concentrations of puriﬁed WT or R137Q Pol
b, washed and bound protein was detected by mouse anti-Pol b antibody and goat anti-mouse IgG/HRP. Color was developed by adding TMB. The
color reaction was stopped by adding 1N HCl. Optical density was read on microplate reader.
3436 Nucleic Acids Research, 2009, Vol. 37,No. 10The amino acid residue Arg137 can be very important
for Pol b function. According to the crystal structure,
R137 maps to the catalytic domain of Pol b (20). At this
site, R137 is required to form hydrogen bonds with other
adjacent amino acid residuals. The substitution of R137Q
might disrupt the formation of hydrogen bonds and
thus impair polymerase activity. Consistent with this spec-
ulation, R137Q has  30% of the DNA polymerase activ-
ity of WT pol b (Figure 1A and B).
Arg137 also serves as a protein posttranslational mod-
iﬁcation site. Recent research by Hottiger and coworkers
(39) found that Arg137 of Pol b was methylated by protein
arginine transferase 1 (PRMT1). Contrary to Hottiger’s
work suggesting Pol b methylation at R137 did not
aﬀect Pol b polymerase activity, our data indicated that
R137Q substitution greatly reduced polymerase activity.
Disparities in the two studies may have been due
to diﬀerences in the properties between glutamine and a
methylated arginine. Methylation of arginine increases
molecular size and hydrophobicity but keeps the positive
charge intact, while the arginine to glutamine substitution
abolishes the positive arginine charge (50).
Our work shows that Arg137 is a regulatory site for
PCNA interaction (Figure 3). PCNA, through its direct
interaction with a broad range of other cellular proteins,
plays essential roles in many aspects of DNA metabolism
in mammalian cells (51). PCNA was reported to enhance
the LP-BER by stimulating FEN1 activity (52). Based on
the polymerase used, the LP-BER can be categorized into
Pol b-independent pathway (13), where Pol d/e are
involved, and Pol b-dependent pathway, where Pol b is
the only polymerase (14). PCNA was once thought only
to be involved in the Pol b-independent LP-BER (13).
However, recently Pol b has been shown to interact with
PCNA (26), implying that PCNA may be also involved in
Pol b-dependent BER. In the current study, the evaluation
of the speciﬁc physiological signiﬁcance of impairment of
the interaction between PCNA and R137Q Pol b was
complicated by the polymerase activity defect. However,
we could imagine that PCNA may regulate BER by facil-
itating Pol b’s recruitment to DNA/protein complexes
formed during BER (39). It is worth to point out that
R137 is also a methylation site of Pol b. A very recent
study showed that Pol b can be methylated by protein
arginine methyltransferase 1at R137 site (39). Consistent
with our result, methylation at R137 also blocks the inter-
action between Pol b and PCNA. Moreover, according
to Hottiger and coworkers (39), methylation at R137 site
of Pol b regulates BER eﬃciency. However, cells carrying
the R137Q polymorphism cannot be methylated at the
R137 site anymore, resulting in a loss of the BER regula-
tory mechanism. In living cells, the R137Q polymorphism
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enzyme activity, reducing protein interaction and blocking
protein posttranslational modiﬁcations, exemplifying
how a subtle change in polymorphism can have signiﬁcant
consequences to cells.
Because DNA continuously undergoes alterations,
either spontaneously or induced by endogenous and exog-
enous factors, highly eﬃcient DNA repair systems are crit-
ical to remove damaged DNA lesions and to maintain
genome integrity. Although the genetic eﬀect of an
individual polymorphism is generally subtle, combinations
of functionally relevant polymorphisms may additively or
synergistically contribute to an increased risk of human
diseases, such as cancers (53). In this study, we demon-
strated that one single nucleotide substitution can have
profound consequences on protein function and overall
phenotype of organisms. The eﬀects of the polymorphism
on proteins are multiple and occur in several segregable
aspects. The eﬀect on each aspect seems subtle, but the
overall consequence can be obvious and dramatic. In this
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3438 Nucleic Acids Research, 2009, Vol. 37,No. 10case, the Pol b R137Q polymorphism may signiﬁcantly
contribute to the initiation and development of human
cancers through its potentially synergistic eﬀects of
impaired polymerase activity, interaction with PCNA
and necessary methylation modiﬁcation.
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